![](https://investorshub.advfn.com/uicon/40490.png?cb=1674047870)
Monday, August 28, 2023 7:12:07 PM
Recent ZVSA News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/30/2024 09:10:48 PM
- ZyVersa Therapeutics Reports Second Quarter, 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/09/2024 08:40:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:30:52 PM
- ZyVersa Therapeutics Announces Published Data Supporting the Rationale for Inhibiting Inflammasome ASC with IC 100 to Control Chronic Inflammation • GlobeNewswire Inc. • 08/07/2024 11:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 12:00:24 PM
- ZyVersa Therapeutics Announces Published Data Demonstrating That Plasma Levels of Inflammasome ASC Show Promise as Biomarker of Early Cognitive Changes in Older Adults • GlobeNewswire Inc. • 07/29/2024 11:45:00 AM
- ZyVersa Therapeutics Selects Obesity and Related Metabolic Complications as Lead Indication for Inflammasome ASC Inhibitor IC 100 • GlobeNewswire Inc. • 07/25/2024 11:57:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 01:35:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 01:35:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 01:35:09 AM
- ZyVersa Therapeutics Announces Publication Demonstrating that Inflammasome ASC Inhibitor IC 100 Restored Retinal Structure and Function in a Retinopathy of Prematurity Animal Model • GlobeNewswire Inc. • 07/18/2024 03:18:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/17/2024 04:15:10 AM
- ZyVersa Therapeutics' CEO, Stephen C. Glover, Is an Invited Speaker at H.C. Wainwright 3rd Annual Kidney Conference to be Held Virtually on July 15, 2024 • GlobeNewswire Inc. • 07/09/2024 11:57:00 AM
- ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/15/2024 12:35:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 12:30:41 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/15/2024 12:25:42 PM
- ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention • GlobeNewswire Inc. • 05/14/2024 11:57:00 AM
- ZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities in Patients with Alzheimer’s Disease • GlobeNewswire Inc. • 04/29/2024 11:57:00 AM
- ZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes • GlobeNewswire Inc. • 04/04/2024 11:57:00 AM
- ZyVersa Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/25/2024 12:17:28 PM
- ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator™ VAR 200 in Patients with Diabetic Kidney Disease • GlobeNewswire Inc. • 03/18/2024 11:57:00 AM
- ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in a Panel Discussion Titled “Inflammation Illuminated,”at Benzinga’s Virtual Healthcare Summit 2024 on March 20, 2024 • GlobeNewswire Inc. • 03/14/2024 11:57:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:00:25 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/08/2024 10:00:16 PM
- ZyVersa Therapeutics Generated Approximately $2.7 Million From Exercise of Warrants Following Excitement Around News That Inflammasome Inhibitors Have Potential to Effectively Treat Obesity • GlobeNewswire Inc. • 02/29/2024 12:57:00 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM